Skip to main content
Clinical Trials/NCT01609868
NCT01609868
Completed
Not Applicable

The Effect of a Liquid Protein Modular on Growth and Outcomes in the NICU

University of Nebraska1 site in 1 country60 target enrollmentJune 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Problem With Growth of an Infant
Sponsor
University of Nebraska
Enrollment
60
Locations
1
Primary Endpoint
Growth in premature infants (percentile ranking at 36 weeks CGA)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The investigators hypothesis that premature infants receiving a commercially available liquid protein modular will have improved growth when compared with premature infants receiving a commercially available powder protein modular.

Registry
clinicaltrials.gov
Start Date
June 2012
End Date
June 2013
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Corrine K. Hanson, PhD

IRB Administrator

University of Nebraska

Eligibility Criteria

Inclusion Criteria

  • Infants less than 2000 gms at birth, receiving maternal breast milk

Exclusion Criteria

  • Infants receiving formula

Outcomes

Primary Outcomes

Growth in premature infants (percentile ranking at 36 weeks CGA)

Time Frame: birth to 36 weeks

Secondary Outcomes

  • GI tolerance(birth to 36 weeks)

Study Sites (1)

Loading locations...

Similar Trials